Controversies in ICD therapy: the subcutaneous defibrillator is superior to the transvenous defibrillator - pro

24 April 2021 (15:57 - 16:05)
Organised by:
Congress Presentation Part of: Pacemakers and ICDs: controversies in device therapy Device Therapy EHRA Premium Access EHRA 2021

ESC 365 is supported by

ESC 365 is supported by